Effect of supplementation in treatment of women with polycystic ovary syndrome
Phase 3
- Conditions
- E28.2Polycystic ovarian syndromePolycystic ovarian syndrome.
- Registration Number
- IRCT201704235623N112
- Lead Sponsor
- Vice chancellor for research, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Patients with PCOS according to Rotterdam criteria
Aged 18 to 40 years
Obtaining informed consent
Exclusion Criteria
Smokers
Taking probiotic supplements
Pregnant women
Endocrine diseases including thyroid, diabetes and/or impaired glucose tolerance.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hs-CRP. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.
- Secondary Outcome Measures
Name Time Method